⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENSC News
Ensysce Biosciences, Inc. Common Stock
Form 8-K
sec.gov
ENSCW
ENSC
Form 8-K
sec.gov
ENSCW
ENSC
Ensysce Biosciences Reports First Quarter 2026 Financial Results
accessnewswire.com
ENSC
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
accessnewswire.com
ENSC
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
accessnewswire.com
ENSC
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSCW
ENSC
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSCW
ENSC
Form 8-K
sec.gov
ENSC
ENSCW